Increased PPARGC1A expression might be an underlying feature of metastatic cancer progression.30 The tumor‐suppressor gene EP300 plays an essential role in cell proliferation and differentiation. The gene discussed is PPARGC1A; the disease is metastatic malignant neoplasm.